Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R.
ALNY Key Statistics
Stock Snapshot
Alnylam Pharmaceuticals(ALNY) stock is priced at $228.80, giving the company a market capitalization of 30.6B. It carries a P/E multiple of 37.81.
On 2026-08-14, Alnylam Pharmaceuticals(ALNY) stock moved within a range of $220.23 to $228.98. With shares now at $228.80, the stock is trading +3.9% above its intraday low and -0.1% below the session's peak.
Trading volume for Alnylam Pharmaceuticals(ALNY) stock has reached 1.52M, versus its average volume of 2.36M.
The stock's 52-week range extends from a low of $197.81 to a high of $495.55.
The stock's 52-week range extends from a low of $197.81 to a high of $495.55.
ALNY News
Alnylam Pharmaceuticals (ALNY) is under closer scrutiny after cutting its full-year 2026 TTR product sales guidance by about $200 million, which it linked to no...
In the second quarter of 2026, Alnylam Pharmaceuticals reported revenue of US$1,290.95 million and net income of US$164.49 million, a shift from a net loss a ye...
The S&P 500 is now sitting just below its record high, with another strong earnings season helping stocks remain near their highs. The strength has not been lim...
Analyst ratings
77%
of 31 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.